Position in MDXG
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,007,625
-$32,682 QoQ
Shares Held
261,721
-0.6% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#40
of 226 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $33,616,297 across 29 Biotechnology names. MDXG ranks #11 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TWST |
Twist Bioscience Corp
|
53,282 | $5,481,652 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
36,368 | $4,170,318 | |
| 3 | VCEL |
Vericel Corp
|
72,852 | $3,241,185 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
36,977 | $2,894,189 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
72,316 | $2,414,631 | |
| 6 | CELC |
Celcuity Inc.
|
19,933 | $2,085,390 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
29,612 | $1,863,779 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
46,550 | $1,727,470 |
All Filings in MDXG
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,007,625 | 261,721 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,040,307 | 263,369 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,076,128 | 306,666 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,343,625 | 335,763 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $7,143,781 | 1,169,195 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $7,931,937 | 1,043,676 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $9,633,352 | 1,001,388 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $6,073,931 | 1,027,738 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,780,968 | 256,994 | Shares | Sole | 2024-07-09 | |
| No filing history on record for this holder in this stock. | ||||||